The role of transient receptor potential channels in metabolic syndrome

Hypertension Research

Volumn 31, Issue 11, 2008, Pages 1989-1995

  Liu, Daoyan ^a   Zhu, Zhiming ^a   Tepel, Martin ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL 3; TRANSIENT RECEPTOR POTENTIAL CHANNEL 5; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; TRANSIENT RECEPTOR POTENTIAL CHANNEL M; TRANSIENT RECEPTOR POTENTIAL CHANNEL M7; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1;

ADIPOGENESIS; ADIPOSE TISSUE; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE COURSE; DRUG MECHANISM; DYSLIPIDEMIA; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; LIPID COMPOSITION; LIPID METABOLISM; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; VASOCONSTRICTION; ANIMAL; DIABETES MELLITUS; PHYSIOLOGY;

ANIMALS; ATHEROSCLEROSIS; DIABETES MELLITUS; HUMANS; HYPERTENSION; LIPID METABOLISM; METABOLIC SYNDROME X; OBESITY; TRANSIENT RECEPTOR POTENTIAL CHANNELS;

EID: 58849109774     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.1989     Document Type: Review

References (53)

1. Eckel RH, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet 2005; 365: 1415-1428.
2. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
3. Chiba Y, Saitoh S, Takagi S, et al: Relationship between visceral fat and cardiovascular disease risk factors: The Tanno and Sobetsu Study. Hypertens Res 2007; 30: 229-236.
4. Scott M, Grundy SM, Cleeman JI, et al: Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752.
5. World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications: Report of a WHO Consultation, Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Organization, 1999.
6. Alberti KG, ZimmetAP, Shaw J: The metabolic syndrome: a new worldwide definition. Lancet 2005; 366: 1059-1062.
7. Eberly LE, Prineas R, Cohen JD, et al, Multiple Risk Factor Intervention TRial Research Group: Metabolic syndrome: risk factor distribution and 18-year mortality in the multiple risk factor intervention trial. Diabetes Care 2006; 29: 123-130.
8. Ninomiya JK, L'Italien G, Criqui MH, Whyte JL, Gamst A, Chen RS: Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 2004; 109: 42-46.
9. Malik S, Wong ND, Franklin SS, et al: Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004; 110: 1245-1250.
10. Cull CA, Jensen CC, Retnakaran R, Holman RR: Impact of the metabolic syndrome on macrovascular and microvascular outcomes in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study 78. Circulation 2007; 116: 2119-2126.
11. Schaefer M: Homo- and heteromeric assembly of TRP channel subunits. Pflügers Arch 2005; 451: 35-42.
12. Nilius B, Owsianik G, Voets T, Peters JA: Transient receptor potential cation channels in disease. Physiol Rev 2007; 87: 165-217.
13. Inoue R, Jensen LJ, Shi J, et al: Transient receptor potential channels in cardiovascular function and disease. Circ Res 2006; 99: 119-131.
14. Zhang LL, Liu DY, Ma LQ, et al: Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity. Circ Res 2007; 100: 1063-1070.
15. Hsu CL, Yen GC: Effects of capsaicin on induction of apoptosis and inhibition of adipogenesis in 3T3-L1 cells. J Agric Food Chem 2007; 55: 1730-1736.
16. Hwang JT, Park IJ, Shin JI, et al: Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem Biophys Res Commun 2005; 338: 694-699.
17. Kang JH, Kim CS, Han IS, Kawada T, Yu R: Capsaicin, a spicy component of hot peppers, modulates adipokine gene expression and protein release from obese-mouse adipose tissues and isolated adipocytes, and suppresses the inflammatory responses of adipose tissue macrophages. FEBS Lett 2007; 581: 4389-4396.
18. Masuda Y, Haramizu S, Oki K, et al: Upregulation of uncoupling proteins by oral administration of capsiate, a nonpungent capsaicin analog. J Appl Physiol 2003; 95: 2408-2415.
19. Melnyk A, Himms-Hagen J: Resistance to aging-associated obesity in capsaicin-desensitized rats one year after treatment. Obes Res 1995; 3: 337-344.
20. Wang X, Miyares RL, Ahern GP: Oleoylethanolamide excites vagal sensory neurones, induces visceral pain and reduces short-term food intake in mice via capsaicin receptor TRPV1. J Physiol 2005; 564 541-547.
21. Bratz IN, Dick GM, Tune JD, et al: Impaired capsaicininduced relaxation of coronary arteries in a porcine model of the metabolic syndrome. Am J Physiol Heart Circ Physiol 2008; 294: H2489-H2496.
22. Razavi R, Chan Y, Afifiyan FN, et al: TRPV1+ sensory neurons control beta cell stress and islet inflammation in autoimmune diabetes. Cell 2006; 127: 1123-1135.
23. Qian F, Huang P, Ma L, Kuznetsov A, Tamarina N, Philipson LH: TRP genes: candidates for nonselective cation channels and store-operated channels in insulin-secreting cells. Diabetes 2002; 51 (Suppl 1): S183-S189.
24. Togashi K, Hara Y, Tominaga T, et al: TRPM2 activation by cyclic ADP-ribose at body temperature is involved in insulin secretion. EMBO J 2006; 25: 1804-1815.
25. Fauconnier J, Lanner JT, Sultan A, et al: Insulin potentiates TRPC3-mediated cation currents in normal but not in insulin- resistant mouse cardiomyocytes. Cardiovasc Res 2007; 73: 376-385.
26. 2+ signaling in glomerular mesangial cells in diabetes. Am J Physiol Renal Physiol 2007; 293: F1381-F1390.
27. Liu D, Maier A, Scholze A, et al: High glucose enhances transient receptor potential channel canonical type 6 (TRPC6)-dependent calcium influx in human platelets via phosphatidylinositol 3-kinase-dependent pathway. Arterioscler Thromb Vasc Biol 2008; 28: 746-751.
28. Liu DY, Scholze A, Zhu ZM, et al: Increased transient receptor potential channel TRPC3 expression in spontaneously hypertensive rats. Am J Hypertens 2005; 18: 1503-1507.
29. Liu DY, Scholze A, Kreutz R, et al: Monocytes from spontaneously hypertensive rats show increased store-operated and second messenger-operated calcium influx mediated by transient receptor potential canonical type 3 channels. Am J Hypertens 2007; 20 1111-1118.
30. -/- mice. Mol Cell Biol 2005; 25: 6980-6989.
31. Trebak M, Vazquez G, Bird GS, Putney JW Jr: The TRPC3/6/7 subfamily of cation channels. Cell Calcium 2003; 33: 451-461.
32. 2+ entry in purinergically stimulated aorta smooth muscle cells. Circ Res 2007; 101: 1030-1038.
33. Bae YM, Kim A, Lee YJ, et al: Enhancement of receptor-operated cation current and TRPC6 expression in arterial smooth muscle cells of deoxycorticosterone acetate-salt hypertensive rats. J Hypertens 2007; 25: 809-817.
34. Wang Y, Wang DH: A novel mechanism contributing to development of Dahl salt-sensitive hypertension: Role of the transient receptor potential vanilloid type 1. Hypertension 2006; 47: 609-614.
35. Touyz RM, He Y, Montezano AC, et al: Differential regulation of transient receptor potential melastatin 6 and 7 cation channels by ANG II in vascular smooth muscle cells from spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 2006; 290: R73-R78.
36. Thilo F, Scholze A, Liu DY, Zidek W, Tepel M: Association of transient receptor potential canonical type 3 (TRPC3) channel transcripts with proinflammatory cytokines. Arch Biochem Biophys 2008; 471: 57-62.
37. Liu DY, Scholze A, Zhu ZM, et al: Transient receptor potential channels in essential hypertension. J Hypertens 2006; 24: 1105-1114.
38. Liu DY, Thilo F, Scholze A, et al: Increased store-operated and 1-oleoyl-2-acetyl-sn-glycerol-induced calcium influx in monocytes is mediated by transient receptor potential canonical channels in human essential hypertension. J Hypertens 2007; 25: 799-808.
39. Tong Q, Hirschler-Laszkiewicz I, Zhang W, et al: TRPC3 is the erythropoietin-regulated calcium channel in human erythroid cells. J Biol Chem 2008; 283: 10385-10395.
40. Stefanini M, UrbasIJV, Urbas JE: Gaisböck's syndrome: its hematologic, biochemical and hormonal parameters. Angiology 1978; 29: 520-533.
41. Smith KJ, Bleyer AJ, Little WC, Sane DC: The cardiovascular effects of erythropoietin. Cardiovasc Res 2003; 59: 538-548.
42. Manjunatha H, Srinivasan K: Hypolipidemic and antioxidant effects of curcumin and capsaicin in high-fat-fed rats. Can J Physiol Pharmacol 2007; 85: 588-596.
43. Tani Y, Fujioka T, Sumioka M, Furuichi Y, Hamada H, Watanabe T: Effects of capsinoid on serum and liver lipids in hyperlipidemic rats. J Nutr Sci Vitaminol (Tokyo) 2004; 50: 351-355.
44. 2+ entry dependent on TRPC1. Circ Res 2003; 93: 839-847.
45. Liu M, Huang W, Wu D, Priestley JV: TRPV1, but not P2X, requires cholesterol for its function and membrane expression in rat nociceptors. Eur J Neurosci 2006; 24: 1-6.
46. So I, Chae MR, Kim SJ, Lee SW: Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces the change of calcium mobilization via TRPC ion channels in cultured human corporal smooth muscle cells. Int J Impot Res 2005; 17: 475-483.
47. Berthier A, Lemaire-Ewing S, Prunet C, et al: Involvement of a calcium-dependent dephosphorylation of BAD associated with the localization of Trpc-1 within lipid rafts in 7-ketocholesterol-induced THP-1 cell apoptosis. Cell Death Differ 2004; 11: 897-905.
48. Beech DJ: Ion channel switching and activation in smooth-muscle cells of occlusive vascular diseases. Biochem Soc Trans 2007; 35: 890-894.
49. Kumar B, Dreja K, Shah SS, et al: Upregulated TRPC1 channel in vascular injury in vivo and its role in human neointimal hyperplasia. Circ Res 2006; 98: 557-563.
50. Takahashi Y, Watanabe H, Murakami M, et al: Involvement of transient receptor potential canonical 1 (TRPC1) in angiotensin II-induced vascular smooth muscle cell hypertrophy. Atherosclerosis 2007; 195: 287-296.
51. Kwan HY, Huang Y, Yao X: TRP channels in endothelial function and dysfunction. Biochim Biophys Acta 2007; 1772: 907-914.
52. Roberts LA, Connor M: TRPV1 antagonists as a potential treatment for hyperalgesia. Recent Patents CNS Drug Discov 2006; 1: 65-76.
53. Suri A, Szallasi A: The emerging role of TRPV1 in diabetes and obesity. Trends Pharmacol Sci 2008; 29: 29-36.